|
US3536809A
(en)
*
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
GB1478759A
(en)
|
1974-11-18 |
1977-07-06 |
Alza Corp |
Process for forming outlet passageways in pills using a laser
|
|
US4002531A
(en)
*
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4200098A
(en)
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
ATE12348T1
(de)
|
1980-11-10 |
1985-04-15 |
Gersonde Klaus Prof Dr |
Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens.
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4640835A
(en)
*
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
JPS58118008A
(ja)
|
1982-01-06 |
1983-07-13 |
Nec Corp |
デ−タ処理装置
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
US4542025A
(en)
*
|
1982-07-29 |
1985-09-17 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
JPS607934A
(ja)
|
1983-06-29 |
1985-01-16 |
Dai Ichi Seiyaku Co Ltd |
リポソ−ムの製造方法
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
DE3486459D1
(de)
|
1983-09-26 |
1997-12-11 |
Udo Dr Med Ehrenfeld |
Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
FR2621486B1
(fr)
|
1987-10-07 |
1990-01-26 |
Synthelabo |
Utilisation de derives de pyrrolo(3,2,1-hi)indole pour obtenir un medicament destine au traitement du diabete
|
|
US4496689A
(en)
*
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5231112A
(en)
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
KR890002631B1
(ko)
|
1984-10-04 |
1989-07-21 |
몬산토 캄파니 |
생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
|
|
IE58110B1
(en)
*
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US5171578A
(en)
|
1985-06-26 |
1992-12-15 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
US5059421A
(en)
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
|
US4885172A
(en)
|
1985-06-26 |
1989-12-05 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
|
US4684479A
(en)
|
1985-08-14 |
1987-08-04 |
Arrigo Joseph S D |
Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
|
|
US6759057B1
(en)
*
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
IE60901B1
(en)
*
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
WO1989001489A1
(en)
|
1987-08-10 |
1989-02-23 |
Commonwealth Scientific And Industrial Research Or |
Control of angiogenesis and compositions and methods therefor
|
|
AU598958B2
(en)
|
1987-11-12 |
1990-07-05 |
Vestar, Inc. |
Improved amphotericin b liposome preparation
|
|
US4904584A
(en)
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
JPH02226533A
(ja)
|
1989-02-27 |
1990-09-10 |
Mitsubishi Electric Corp |
情報記録媒体
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
ES2084698T5
(es)
|
1989-05-04 |
2005-03-01 |
Southern Research Institute |
Procedimiento de encapsulacion.
|
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US6517859B1
(en)
|
1990-05-16 |
2003-02-11 |
Southern Research Institute |
Microcapsules for administration of neuroactive agents
|
|
US5215680A
(en)
*
|
1990-07-10 |
1993-06-01 |
Cavitation-Control Technology, Inc. |
Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
|
|
US7115554B1
(en)
|
1993-05-06 |
2006-10-03 |
Acorda Therapeutics, Inc. |
Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
|
|
GB9107566D0
(en)
|
1991-04-10 |
1991-05-29 |
Ludwig Inst Cancer Res |
Glial mitogenic factors,their preparation and use
|
|
US5716930A
(en)
*
|
1991-04-10 |
1998-02-10 |
Ludwig Institute For Cancer Research |
Glial growth factors
|
|
US5530109A
(en)
*
|
1991-04-10 |
1996-06-25 |
Ludwig Institute For Cancer Research |
DNA encoding glial mitogenic factors
|
|
US5367060A
(en)
|
1991-05-24 |
1994-11-22 |
Genentech, Inc. |
Structure, production and use of heregulin
|
|
US5834229A
(en)
|
1991-05-24 |
1998-11-10 |
Genentech, Inc. |
Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
|
|
IL101943A0
(en)
*
|
1991-05-24 |
1992-12-30 |
Genentech Inc |
Structure,production and use of heregulin
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US7037888B1
(en)
*
|
1992-04-03 |
2006-05-02 |
Acorda Therapeutics, Inc. |
Methods for treating muscle diseases and disorders
|
|
US6087323A
(en)
|
1992-04-03 |
2000-07-11 |
Cambridge Neuroscience, Inc. |
Use of neuregulins as modulators of cellular communication
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5554730A
(en)
*
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
EP0688429B1
(en)
|
1993-03-09 |
1998-02-11 |
Epic Therapeutics, Inc.. |
Macromolecular microparticles and methods of production
|
|
CA2126619A1
(en)
|
1993-06-24 |
1994-12-25 |
Yasutaka Igari |
Sustained-release preparation of anti-endothelin substance
|
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US5770567A
(en)
*
|
1994-11-14 |
1998-06-23 |
Genentech, Inc. |
Sensory and motor neuron derived factor (SMDF)
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US6169070B1
(en)
*
|
1995-03-10 |
2001-01-02 |
Genentech, Inc. |
Mer receptor activation by gas6
|
|
US6750196B1
(en)
*
|
1995-03-27 |
2004-06-15 |
Acorda Therapeutics |
Methods of treating disorders of the eye
|
|
US5714385A
(en)
*
|
1995-05-10 |
1998-02-03 |
Genentech, Inc. |
Media for culturing schwann cells
|
|
US5721139A
(en)
*
|
1995-05-10 |
1998-02-24 |
Genentech, Inc. |
Isolating and culturing schwann cells
|
|
US6033660A
(en)
*
|
1995-05-10 |
2000-03-07 |
Genentech, Inc. |
Method of treating a nervous system injury with cultured schwann cells
|
|
CA2224381A1
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
|
US5912326A
(en)
|
1995-09-08 |
1999-06-15 |
President And Fellows Of Harvard College |
Cerebellum-derived growth factors
|
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
WO1998002541A1
(en)
*
|
1996-07-12 |
1998-01-22 |
Genentech, Inc. |
Gamma-heregulin
|
|
EP0929293B1
(en)
|
1996-08-23 |
2003-10-22 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
JP2001503396A
(ja)
|
1996-10-11 |
2001-03-13 |
アルザ コーポレイション |
治療用リポソーム組成物および方法
|
|
AU725257B2
(en)
|
1996-10-15 |
2000-10-12 |
Transave, Inc. |
N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
|
|
DE69735002T2
(de)
*
|
1996-10-25 |
2006-10-26 |
Shire Laboratories, Inc. |
Osmotisches Verabreichungssystem für lösliche Dosen
|
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
CA2219698C
(en)
*
|
1996-10-31 |
2007-09-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6593290B1
(en)
*
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6395302B1
(en)
|
1996-11-19 |
2002-05-28 |
Octoplus B.V. |
Method for the preparation of microspheres which contain colloidal systems
|
|
EP0842657A1
(en)
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Microspheres for controlled release and processes to prepare these microspheres
|
|
KR20000057693A
(ko)
*
|
1996-12-20 |
2000-09-25 |
다케다 야쿠힌 고교 가부시키가이샤 |
지효성 제제의 제조 방법
|
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
|
US6136558A
(en)
|
1997-02-10 |
2000-10-24 |
Genentech, Inc. |
Heregulin variants
|
|
AU732027B2
(en)
*
|
1997-02-10 |
2001-04-12 |
Genentech Inc. |
Heregulin variants
|
|
AU7727298A
(en)
|
1997-06-06 |
1998-12-21 |
Regents Of The University Of Michigan, The |
Neuregulin response element and uses therefor
|
|
US6121415A
(en)
*
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
|
DE19747261A1
(de)
*
|
1997-10-25 |
1999-04-29 |
Bayer Ag |
Osmotisches Arzneimittelfreisetzungssystem
|
|
KR20010031103A
(ko)
*
|
1997-10-14 |
2001-04-16 |
버틀러 그레고리 비. |
네우레굴린을 사용하는 치료요법적 방법
|
|
NZ505651A
(en)
|
1998-01-16 |
2003-08-29 |
Takeda Chemical Industries Ltd |
Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
KR19990085365A
(ko)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
|
US6713086B2
(en)
|
1998-12-18 |
2004-03-30 |
Abbott Laboratories |
Controlled release formulation of divalproex sodium
|
|
AUPP785098A0
(en)
*
|
1998-12-21 |
1999-01-21 |
Victor Chang Cardiac Research Institute, The |
Treatment of heart disease
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6446242B1
(en)
*
|
1999-04-02 |
2002-09-03 |
Actel Corporation |
Method and apparatus for storing a validation number in a field-programmable gate array
|
|
US6635249B1
(en)
*
|
1999-04-23 |
2003-10-21 |
Cenes Pharmaceuticals, Inc. |
Methods for treating congestive heart failure
|
|
CN1138785C
(zh)
*
|
1999-06-04 |
2004-02-18 |
周明东 |
生长因子神经调节蛋白及其类似物的新应用
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US6352721B1
(en)
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
|
CA2409996C
(en)
*
|
2000-05-23 |
2016-03-01 |
Cenes Pharmaceuticals, Inc. |
Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
|
CN100345535C
(zh)
|
2000-06-27 |
2007-10-31 |
株式会社Mitech |
胰岛素控释制剂及其方法
|
|
DE60140625D1
(de)
|
2000-08-15 |
2010-01-07 |
Univ Illinois |
Verfahren zur herstellung von mikropartikeln
|
|
US6866866B1
(en)
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6436386B1
(en)
|
2000-11-14 |
2002-08-20 |
Shearwater Corporation |
Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
|
|
IN190699B
(enExample)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
|
US6890918B2
(en)
|
2001-04-30 |
2005-05-10 |
Shire Laboratories, Inc. |
Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers
|
|
AR033903A1
(es)
|
2001-05-21 |
2004-01-07 |
Inhale Therapeutic Syst |
Una composicion de insulina modificada quimicamente para la administracion pulmonar
|
|
US6838093B2
(en)
|
2001-06-01 |
2005-01-04 |
Shire Laboratories, Inc. |
System for osmotic delivery of pharmaceutically active agents
|
|
EP2400021B1
(en)
|
2002-03-26 |
2016-11-30 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
ErbB3 based methods and compositions for treating neoplasms
|
|
WO2003099320A1
(en)
|
2002-05-24 |
2003-12-04 |
Zensun (Shanghai) Sci-Tech.Ltd |
Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
|
|
CN1498656A
(zh)
*
|
2002-11-08 |
2004-05-26 |
上海泽生科技开发有限公司 |
神经调节蛋白用于心肌梗死治疗的方法和组合物
|
|
US20070213264A1
(en)
*
|
2005-12-02 |
2007-09-13 |
Mingdong Zhou |
Neuregulin variants and methods of screening and using thereof
|
|
EP3363455A1
(en)
|
2005-12-30 |
2018-08-22 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for improved cardiac function
|
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
|
JP4616237B2
(ja)
|
2006-11-07 |
2011-01-19 |
日本電信電話株式会社 |
シリコン化合物薄膜の形成方法
|
|
US20090156488A1
(en)
|
2007-09-12 |
2009-06-18 |
Zensun (Shanghai) Science & Technology Limited |
Use of neuregulin for organ preservation
|
|
WO2010060265A1
(en)
|
2008-11-28 |
2010-06-03 |
Zensun (Shanghai) Science & Technology Limited |
Neuregulin peptides and their use
|
|
JP2012509908A
(ja)
|
2008-11-28 |
2012-04-26 |
ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド |
ニューレグリン及び心臓幹細胞
|
|
EP2440236B1
(en)
|
2009-06-09 |
2016-05-04 |
Zensun (Shanghai) Science and Technology Limited |
Neuregulin based methods for treating heart failure
|
|
ES2748886T3
(es)
|
2009-06-09 |
2020-03-18 |
Zensun Shanghai Science & Tech Co Ltd |
Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
|
|
JP6096262B2
(ja)
|
2009-08-25 |
2017-03-15 |
ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． |
ニューレグリンに基づく心不全の治療方法
|
|
CN102139095A
(zh)
|
2010-01-29 |
2011-08-03 |
上海泽生科技开发有限公司 |
神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
|
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun （Shanghai）Science & Technology Limited |
Compositions and methods for treating heart failure
|
|
BR112015029293A2
(pt)
|
2013-05-22 |
2018-04-24 |
Zensun Shanghai Science & Tech Ltd |
método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero
|
|
CN110946993A
(zh)
|
2014-01-03 |
2020-04-03 |
上海泽生科技开发股份有限公司 |
纽兰格林制剂的配方
|
|
CN105497876B
(zh)
|
2014-09-24 |
2021-01-15 |
上海泽生科技开发股份有限公司 |
神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
|
|
CN105561298A
(zh)
|
2014-10-17 |
2016-05-11 |
上海泽生科技开发有限公司 |
神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
|